Skip to main content

Videos

VIDEO
March 01, 2021
In this video, Psych Congress Steering Committee member Vladimir Maletic, MD, MS, discusses the concept of complex attention/deficit-hyperactivity disorder, how it is defined, and how to respond to…
VIDEO
February 22, 2021
Psych Congress Steering Committee member Vladimir Maletic, MD, MS, summarizes some recent findings related to genome‑wide association studies examining attention/deficit-hyperactivity disorder (ADHD).
February 19, 2021
With the approval of psychedelic medicines imminent, the Psychiatry & Behavioral Health Learning Network (PBHLN) has announced that its inaugural Sana Symposium will take place Sept. 17-19, 2021.
PSYCHFOCUS
February 19, 2021
Jonathan E. Alpert, MD, PhD, of Albert Einstein College of Medicine and Montefiore Medical Center, New York City, New York, discusses the occurrence of medical comorbidities in patients with…
VIDEO
February 18, 2021
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses an article he cowrote on nonstimulant treatment options for pediatric attention-deficit/hyperactivity disorder (ADHD).
VIDEO
February 16, 2021
In this video, Psych Congress Steering Committee member Vladimir Maletic, MD, MS, discusses the noncore symptoms of attention/deficit-hyperactivity disorder (ADHD) and how they are relevant to…
VIDEO
February 08, 2021
Using a genetics-based statistical approach, researchers from the United Kingdom found attention-deficit/hyperactivity disorder (ADHD) to have a causal effect on childhood obesity and coronary artery…
January 21, 2021
In this video, Leslie Citrome, MD, MPH, discusses the use of long-acting injectable antipsychotics in the treatment of schizophrenia and bipolar disorder.
VIDEO
January 20, 2021
Tycho Dekkers, PhD, discusses his research on Behavioral Parent Training techniques, which was presented at the recent American Professional Society of ADHD and Related Disorders 2021 Virtual…
VIDEO
January 15, 2021
Kristin Bigos, PhD, of Johns Hopkins Medicine, Baltimore, Maryland, discusses research that could advance the development of treatments focused on cognition in people with schizophrenia or other…
Back to Top